Melanoma Development: Current Knowledge on Melanoma Pathogenesis.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Melanoma is characterized by uncontrolled atypical melanocyte proliferation.
• Pathogenesis involves self-sufficiency of growth factors, apoptosis evasion, angiogenesis, invasion, and metastasis.
• Molecular events include oncogene activation, tumor suppressor inactivation, and epigenetic alterations.

Purpose of the Study:

• To elucidate the complex signaling pathways and molecular mechanisms underlying melanoma pathogenesis.
• To highlight the importance of understanding melanoma biology for therapeutic development.

Main Methods:

• Analysis of gene aberrations in melanoma genomes.
• Investigation of molecular and epigenetic mechanisms driving melanoma progression.
• Review of key signaling pathways implicated in melanoma.

Main Results:

• Identified complex interactions within signaling pathways (MAPK, PI3K/PTEN/AKT, MITF).
• Highlighted the role of genetic instability and selective mutations in melanoma progression.
• Confirmed involvement of genetic predisposition, mutagenesis, and immune suppression.

Conclusions:

• Understanding melanoma pathogenesis is key to developing effective targeted therapies and immunotherapies.
• Targeted drugs (vemurafenib, dabrafenib, trametinib) and immunotherapies (pembrolizumab, nivolumab, ipilimumab) show significant promise.
• Advances in understanding melanoma biology have led to breakthroughs in patient treatment.